-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. What You Will Achieve The ADC Chemistry (AC) group is seeking a
-
small molecule NMR and Mass Spectrometry to drive the design and synthesis of Pfizer's medicinal chemistry portfolio. You will work closely with medicinal chemistry to elucidate compound structures and
-
pharmaceutical science, chemistry, engineering (chemical or mechanical), biology, physics, or related field with 3+ years of experience or a Master's Degree (MA/MS) in the same fields. Excellent written and oral
-
scientists engage in all facets of development from small scale synthesis in support of medicinal chemistry programs, to the development of the commercial synthetic route. CRD scientists partner with
-
technical expertise required for project progression. The individual will also work closely with the Medicinal Chemistry and Oncology Biology groups to innovate and develop the next-generation of therapies
-
for support and expertise. The role also involves assisting in the resolution of technical challenges related to particle analysis. Qualifications Must-Have Ph.D. in Analytical Chemistry or a related field with
-
Bachelor of Science degree in Engineering, Biology, Chemistry, Pharmacology, Computer Science or a related field with 6+ years of relevant experience. Excellent organization and planning skills and the
-
timely documentation of experiments in a laboratory notebook Qualifications Must-Have BS degree in biology, chemistry, biochemistry, chemical engineering, or related field with 2-5 years relevant
-
or MS in Chemistry, Biochemistry, or related discipline with at least at least 6 (BS) or 4 (MS) years of relevant GLP work experience is required. Experience and proficiency in separation-based analytical
-
medicinal chemistry programs, to the development of the commercial synthetic route. CRD scientists partner with manufacturing specialists for API synthesis in kilo-lab and pilot plant facilities, as